Showing results (321-330 of 387) with videos related to

Sort By:
Pageof 39
NPJ Parkinson'S Disease|June 2, 2022
Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle countingLara Blömeke, Marlene Pils, Victoria Kraemer-Schulien, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2019
Risk of Parkinson's disease dementia related to level I MDS PD-MCIJeroen Hoogland, Judith A Boel, Rob M A de Bie, et al.
Journal of Parkinson'S Disease|July 17, 2023
Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease ProgressionMichael C Brumm, Andrew Siderowf, Tanya Simuni, et al.
JAMA Neurology|December 4, 2018
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement DisordersBob Olsson, Erik Portelius, Nicholas C Cullen, et al.
International Psychogeriatrics|August 26, 2015
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trialPaul B Rosenberg, Lea T Drye, Anton P Porsteinsson, et al.
Journal of Alzheimer'S Disease : JAD|March 18, 2017
Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International CohortMilica G Kramberger, Bjørn Auestad, Sara Garcia-Ptacek, et al.
Annals of Neurology|June 17, 2020
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's DiseaseDavid J Irwin, Janel Fedler, Christopher S Coffey, et al.
Parkinsonism & Related Disorders|February 11, 2019
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)Neha Prakash, Chelsea Caspell-Garcia, Christopher Coffey, et al.
Movement Disorders Clinical Practice|July 20, 2024
Improving Parkinson's Disease Care through Systematic Screening for DepressionConnie Marras, Zachary Meyer, Hongliang Liu, et al.
Movement Disorders Clinical Practice|June 19, 2023
Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory StudyDaniel Weintraub, Marina Picillo, Hyunkeun Ryan Cho, et al.
Pageof 39